Over the past several years, Accelerate Diagnostics, together with our scientific collaborators, conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.
These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labeling for instructions for use, warnings, and limitations specific to each product and region.Okay, I understand. Show me the publications.
Impact of rapid antimicrobial susceptibility test Accelerate Pheno™ in antimicrobial stewardship of sepsis
Belati A, De Socio G, Paggi R, et al. (University of Perugia, Perugia General Hospital)
Impact of a rapid diagnostic system on the management of septic shock patients
Placanica P, Carfagna P, Lauri S, Gaudio M (Azienda Ospedaliera S. Giovanni Addolorata)
The clinical utilisation of a rapid Accelerate Pheno platform in complex patient groups and its potential effect on antimicrobial stewardship
Wu H, Wilson S, Xu Mccrae L, et al. (PHE Public Health Laboratory Birmingham)
Real life experience and case examples from an evaluation of the Accelerate PhenoTest ™ BC Kit used in a clinical routine setting
Wilke M, Heinlein W, Worf K, et al. (inspiring health GmbH, Werner Forßmann Hospital)
A hospital perspective decision model to determine the clinical and economical effectiveness of the new Accelerate PhenoTest™ BC Kit
Wilke M, Heinlein W, Worf K, et al. (inspiring-health GmbH, Accelerate Diagnostics, Werner-Forßmann-Hospital)
Is the juice worth the squeeze? Rapid Identification and Antimicrobial Susceptibility Testing using the Accelerate Pheno™ system
Chapin K, Rogers R, Zaninni A, et al. (Alpert Brown Medical School and Lifespan Hospitals)
Using the Accelerate PhenoTest (BC kit) for rapid reporting of antimicrobial susceptibility in real life
Fuentes A, Chueca N, de Salazar A, et al. (Hospital Universitario San Cecilio)
Evaluation of Rapid Antimicrobial Susceptibility Testing Methods for Gram-Negative Isolates
Bhalodi A, Miquirray S, Perez I, et al. (Accelerate Diagnostics Inc.)
Identification of difficult to detect MRSA/MSSA strains by two commercial AST methods
Towne J, Humphries R (Accelerate Diagnostics Inc.)
Pathogen recovery from bronchoalveolar lavage specimens using an enhanced culture method as compared to standard of care testing
Campeau S, Buchan B, Culbreath K, et al. (Accelerate Diagnostics Inc, Medical College of Wisconsin, Tricore Reference Laboratories, Indiana University School of Medicine)